Carol Pollock
Carol Pollock
Professor of Medicine University of Sydney
Verified email at
TitleCited byYear
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
ADVANCE Collaborative Group
New England journal of medicine 358 (24), 2560-2572, 2008
A randomized, controlled trial of early versus late initiation of dialysis
BA Cooper, P Branley, L Bulfone, JF Collins, JC Craig, MB Fraenkel, ...
New England Journal of Medicine 363 (7), 609-619, 2010
The influence of dialysis treatment modality on the decline of remaining renal function.
MJ Lysaght, EF Vonesh, F Gotch, L Ibels, M Keen, B Lindholm, KD Nolph, ...
ASAIO transactions 37 (4), 598-604, 1991
Glucose handling by the kidney
A Mather, C Pollock
Kidney international 79, S1-S6, 2011
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
A Levin, M Tonelli, J Bonventre, J Coresh, JA Donner, AB Fogo, CS Fox, ...
The Lancet 390 (10105), 1888-1917, 2017
Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis
WK Lo, JM Bargman, J Burkart, RT Krediet, C Pollock, H Kawanishi, ...
Peritoneal Dialysis International 26 (5), 520-522, 2006
Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD
BA Cooper, EL Penne, LH Bartlett, CA Pollock
American Journal of Kidney Diseases 43 (1), 61-66, 2004
Validity of subjective global assessment as a nutritional marker in end-stage renal disease
BA Cooper, LH Bartlett, A Aslani, BJ Allen, LS Ibels, CA Pollock
American journal of kidney diseases 40 (1), 126-132, 2002
Integrated actions of transforming growth factor-β1 and connective tissue growth factor in renal fibrosis
W Qi, S Twigg, X Chen, TS Polhill, P Poronnik, RE Gilbert, CA Pollock
American Journal of Physiology-Renal Physiology 288 (4), F800-F809, 2005
Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells
SC Jones, HJ Saunders, W Qi, CA Pollock
Diabetologia 42 (9), 1113-1119, 1999
Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ...
New England Journal of Medicine 380 (24), 2295-2306, 2019
Comparing different methods of assessing body composition in end-stage renal failure
BA Cooper, A Aslani, M Ryan, FYP Zhu, LS Ibels, BJ Allen, CA Pollock
Kidney international 58 (1), 408-416, 2000
Effects of SGLT2 inhibition in human kidney proximal tubular cells—renoprotection in diabetic nephropathy?
U Panchapakesan, K Pegg, S Gross, MG Komala, H Mudaliar, J Forbes, ...
PloS one 8 (2), e54442, 2013
Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts
S Zafiriou, SR Stanners, S Saad, TS Polhill, P Poronnik, CA Pollock
Journal of the American Society of Nephrology 16 (3), 638-645, 2005
Paracrine stimulation of human renal fibroblasts by proximal tubule cells
DW Johnson, HJ Saunders, RC Baxter, MJ Field, CA Pollock
Kidney international 54 (3), 747-757, 1998
The renal cortical fibroblast in renal tubulointerstitial fibrosis
W Qi, X Chen, P Poronnik, CA Pollock
The international journal of biochemistry & cell biology 38 (1), 1-5, 2006
PPARγ agonists exert antifibrotic effects in renal tubular cells exposed to high glucose
U Panchapakesan, S Sumual, CA Pollock, X Chen
American Journal of Physiology-Renal Physiology 289 (5), F1153-F1158, 2005
Erythropoiesis‐stimulating agent hyporesponsiveness
DW Johnson, CA Pollock, IC Macdougall
Nephrology 12 (4), 321-330, 2007
Transforming growth factor-β/connective tissue growth factor axis in the kidney
W Qi, X Chen, P Poronnik, CA Pollock
The international journal of biochemistry & cell biology 40 (1), 9-13, 2008
Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats
RE Gilbert, JL Wilkinson-Berka, DW Johnson, A Cox, T Soulis, LL Wu, ...
Kidney international 54 (4), 1052-1062, 1998
The system can't perform the operation now. Try again later.
Articles 1–20